In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis

Abstract Plants are endowed with a large pool of structurally diverse small molecules known as secondary metabolites. The present study aims to virtually screen these plant secondary metabolites (PSM) for their possible anti-SARS-CoV-2 properties targeting four proteins/ enzymes which govern viral p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hariprasad Puttaswamy, Hittanahallikoppal Gajendramurthy Gowtham, Monu Dinesh Ojha, Ajay Yadav, Gourav Choudhir, Vasantharaja Raguraman, Bhani Kongkham, Koushalya Selvaraju, Shazia Shareef, Priyanka Gehlot, Faiz Ahamed, Leena Chauhan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dec376b8a95049a1b15ab9c2533a59dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dec376b8a95049a1b15ab9c2533a59dd
record_format dspace
spelling oai:doaj.org-article:dec376b8a95049a1b15ab9c2533a59dd2021-12-02T15:09:57ZIn silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis10.1038/s41598-020-77602-02045-2322https://doaj.org/article/dec376b8a95049a1b15ab9c2533a59dd2020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77602-0https://doaj.org/toc/2045-2322Abstract Plants are endowed with a large pool of structurally diverse small molecules known as secondary metabolites. The present study aims to virtually screen these plant secondary metabolites (PSM) for their possible anti-SARS-CoV-2 properties targeting four proteins/ enzymes which govern viral pathogenesis. Results of molecular docking with 4,704 ligands against four target proteins, and data analysis revealed a unique pattern of structurally similar PSM interacting with the target proteins. Among the top-ranked PSM which recorded lower binding energy (BE), > 50% were triterpenoids which interacted strongly with viral spike protein—receptor binding domain, > 32% molecules which showed better interaction with the active site of human transmembrane serine protease were belongs to flavonoids and their glycosides, > 16% of flavonol glycosides and > 16% anthocyanidins recorded lower BE against active site of viral main protease and > 13% flavonol glycoside strongly interacted with active site of viral RNA-dependent RNA polymerase. The primary concern about these PSM is their bioavailability. However, several PSM recorded higher bioavailability score and found fulfilling most of the drug-likeness characters as per Lipinski's rule (Coagulin K, Kamalachalcone C, Ginkgetin, Isoginkgetin, 3,3′-Biplumbagin, Chrysophanein, Aromoline, etc.). Natural occurrence, bio-transformation, bioavailability of selected PSM and their interaction with the target site of selected proteins were discussed in detail. Present study provides a platform for researchers to explore the possible use of selected PSM to prevent/ cure the COVID-19 by subjecting them for thorough in vitro and in vivo evaluation for the capabilities to interfering with the process of viral host cell recognition, entry and replication.Hariprasad PuttaswamyHittanahallikoppal Gajendramurthy GowthamMonu Dinesh OjhaAjay YadavGourav ChoudhirVasantharaja RaguramanBhani KongkhamKoushalya SelvarajuShazia ShareefPriyanka GehlotFaiz AhamedLeena ChauhanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-24 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hariprasad Puttaswamy
Hittanahallikoppal Gajendramurthy Gowtham
Monu Dinesh Ojha
Ajay Yadav
Gourav Choudhir
Vasantharaja Raguraman
Bhani Kongkham
Koushalya Selvaraju
Shazia Shareef
Priyanka Gehlot
Faiz Ahamed
Leena Chauhan
In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis
description Abstract Plants are endowed with a large pool of structurally diverse small molecules known as secondary metabolites. The present study aims to virtually screen these plant secondary metabolites (PSM) for their possible anti-SARS-CoV-2 properties targeting four proteins/ enzymes which govern viral pathogenesis. Results of molecular docking with 4,704 ligands against four target proteins, and data analysis revealed a unique pattern of structurally similar PSM interacting with the target proteins. Among the top-ranked PSM which recorded lower binding energy (BE), > 50% were triterpenoids which interacted strongly with viral spike protein—receptor binding domain, > 32% molecules which showed better interaction with the active site of human transmembrane serine protease were belongs to flavonoids and their glycosides, > 16% of flavonol glycosides and > 16% anthocyanidins recorded lower BE against active site of viral main protease and > 13% flavonol glycoside strongly interacted with active site of viral RNA-dependent RNA polymerase. The primary concern about these PSM is their bioavailability. However, several PSM recorded higher bioavailability score and found fulfilling most of the drug-likeness characters as per Lipinski's rule (Coagulin K, Kamalachalcone C, Ginkgetin, Isoginkgetin, 3,3′-Biplumbagin, Chrysophanein, Aromoline, etc.). Natural occurrence, bio-transformation, bioavailability of selected PSM and their interaction with the target site of selected proteins were discussed in detail. Present study provides a platform for researchers to explore the possible use of selected PSM to prevent/ cure the COVID-19 by subjecting them for thorough in vitro and in vivo evaluation for the capabilities to interfering with the process of viral host cell recognition, entry and replication.
format article
author Hariprasad Puttaswamy
Hittanahallikoppal Gajendramurthy Gowtham
Monu Dinesh Ojha
Ajay Yadav
Gourav Choudhir
Vasantharaja Raguraman
Bhani Kongkham
Koushalya Selvaraju
Shazia Shareef
Priyanka Gehlot
Faiz Ahamed
Leena Chauhan
author_facet Hariprasad Puttaswamy
Hittanahallikoppal Gajendramurthy Gowtham
Monu Dinesh Ojha
Ajay Yadav
Gourav Choudhir
Vasantharaja Raguraman
Bhani Kongkham
Koushalya Selvaraju
Shazia Shareef
Priyanka Gehlot
Faiz Ahamed
Leena Chauhan
author_sort Hariprasad Puttaswamy
title In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis
title_short In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis
title_full In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis
title_fullStr In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis
title_full_unstemmed In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis
title_sort in silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing sars-cov-2 pathogenesis
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/dec376b8a95049a1b15ab9c2533a59dd
work_keys_str_mv AT hariprasadputtaswamy insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT hittanahallikoppalgajendramurthygowtham insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT monudineshojha insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT ajayyadav insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT gouravchoudhir insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT vasantharajaraguraman insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT bhanikongkham insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT koushalyaselvaraju insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT shaziashareef insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT priyankagehlot insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT faizahamed insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
AT leenachauhan insilicostudiesevidencedtheroleofstructurallydiverseplantsecondarymetabolitesinreducingsarscov2pathogenesis
_version_ 1718387784928985088